The most common type of dwarfism, achondroplasia can now be treated with Voxzogo starting at birth, maximizing children’s growth potential.
CHOC-affiliated blood disorder center administers landmark gene therapy infusion for hemophilia
The center becomes the first in the country to administer a commercial gene therapy infusion to treat Hemophilia A, the common disorder affecting males.
CHOC-led study reveals racial disparities in fatal encounters between youth and law enforcement
CHOC “lets the data speak for itself” in first-of-its-kind study into pediatric injuries sustained during law enforcement encounters.
Evaluating newer medications in the treatment of neonatal seizures; predicting future epilepsy risk after neonatal seizures
CHOC aims to improve care of neonatal seizures through research into medications with fewer side effects than traditional anti-epileptics.
CHOC data scientists win best paper award from peer-reviewed journal
Associates in the CHOC Research Computational and Data Science Program have won a prestigious award from Data in Brief, a national journal.
Pediatric mental health services take the spotlight at Research Day 2023 at CHOC
CHOC’s annual Research Day back in full, in-person swing this year with nearly 80 scientific poster and podium presentations.
